Page 300 - AIDSBK23C
P. 300
Page 300
17 Gottlieb MS. AIDS—past and future. N Engl J Med. 2001;344:1788-1791.
18 Lert F. Advances in HIV treatment and prevention: should treatment optimism lead to
prevention pessimism? AIDS Care. 2000;12:745-755.
19 Blocker ME, Cohen MS. Biologic approaches to the prevention of sexual transmission of
human immunodeficiency virus. Infect Dis Clin North Am. 2000;14:983-999.
20 Centers for Disease Control. Advancing HIV Prevention: New Strategies for a Changing
Epidemic --- United States, 2003. MMWR. 2003;52:329-332.
21 Fauci AS. Multifactorial nature of human immunodeficiency virus disease: implications
for therapy. Science. 1993;262:1011-1018.
22 Sierra S, Kupfer B, Kaiser R. Basics of the virology of HIV-1 and its replication. J Clin
Virol. 2005;34:233-244.
23 Emerman M, Malim MH. HIV-1 regulatory/accessory genes: keys to unraveling viral and
host cell biology. Science. 1998;280:1880-1884.
24 Heeney JL, Dalgleish AG, Weiss RA. Origins of HIV and the evolution of resistance to
AIDS. Science. 2006;313:462-466.
25 Heneine W, Switzer WM, Sandstrom P, et al. Identification of a human population
infected with simian foamy viruses. Nat Med. 1998;4:403-407.
26 Zhu T, Korber BT, Nahmias AJ, Hooper E, Sharp PM, Ho DD. An African HIV-1
sequence from 1959 and implications for the origin of the epidemic. Nature.
1998;391:594-597.
27 Barré-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphocytotropic
retrovirus from a patient at risk for acquired immunodeficiency syndrome (AIDS).
Science. 1983;220:868-871.
28 Levy JA. HIV pathogenesis: 25 years of progress and persistent challenges. AIDS.
2009;23:147-160.
29 Greene WC. AIDS and the immune system. Sci Am. 1993;269:98-105.
30 Sundquist WI, Kräusslich H-G. HIV-1 Assembly, Budding, and Maturation. Cold Spring
Harbor Perspectives in Medicine. March 13, 2012. doi: 10.1101/cshperspect.a006924.
31 Orenstein JM. Ultrastructure of HIV/AIDS. Ultrastruct Pathol. 2002;26:245-250.
